专利号:US-9056816-B2 优先权日:2011-10-25 标 题:Process for the preparation of aliskiren 发明人:BISWAS SUJAY; SRIMURUGAN SANKARESWARAN; KUMAR ANJUL; PANDA ATULYA KUMAR; JAMSHAD DANISH; MASAND MUKESH; BISWAS BIDYUT; BANSAL VIKAS; GUPTA ASHISH KUMAR; VIR DHARAM 权利人:JUBILANT LIFE SCIENCES LTD 摘要:The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate.
专利号:WO-2011148392-A1 优先权日:2010-05-28 标题 :Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof 发明人:SATYANARAYANA REDDY MANNE; THIRUMALAI RAJAN SRINIVASAN; ESWARAIAH SAJJA; VENKAT REDDY GHOJALA; RAMA SUBBA REDDY KARAMALA; SAHADEVA REDDY MARAMREDDY 权利人:MSN LAB LTD; SATYANARAYANA REDDY MANNE; THIRUMALAI RAJAN SRINIVASAN; ESWARAIAH SAJJA; VENKAT REDDY GHOJALA; RAMA SUBBA REDDY KARAMALA; SAHADEVA REDDY MARAMREDDY 摘要:The present invention relates to a process for the preparation of (2S,4S,5S,7S)-N-(2- Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxy propoxy )phenyl]-octanamide compound of formula- 1 and its pharmaceutically acceptable salts thereof. Further, relates to the processes for the preparation of (R)-4-(2-(halomethyl)-3- methylbutyl)-l-methoxy-2-(3-methoxypropoxy) benzene and (R)-2-(4-methoxy-3-(3-methoxy propoxy) benzyl)-3-methyIbutan-l-ol useful intermediates in the synthesis of compound of formula- 1.
专利号:WO-2012078147-A1 优先权日:2010-12-08 标 题:A process for the preparation of intermediates useful in the production of aliskiren 发明人:BHANU MANJUNATH NARAYAN; NAIK SAMIR; THOMAS REJOY 权利人:WATSON LAB INC; BHANU MANJUNATH NARAYAN; NAIK SAMIR; THOMAS REJOY 摘要:A process for preparing 4-[(2R)-2-X-methyl)-3-methylbutyl]-1 -methoxy-2-3(3- methoxypropoxy)-benzene wherein X is a leaving group and use of this compound in the synthesis of aliskiren.
专利号:US-9187409-B2 优先权日:2010-10-19 标 题 :Synthesis of Aliskiren 发明人:SHANKAR RAMA; RAO VADALI LAKSHMANA; KUMAR PALLA VIJAY; SWAMY SAIDUGARI; RAO DASARI SRINIVASA; POTLA SRINIVASA RAO; NAGARAJU MITTAPELLY; RAVIKANTH JALDU; RAVI VIJAYA KRISHNA; MANUKONDA SESHADRI RAO; RAMESH DANDALA 权利人:SHANKAR RAMA; RAO VADALI LAKSHMANA; KUMAR PALLA VIJAY; SWAMY SAIDUGARI; RAO DASARI SRINIVASA; POTLA SRINIVASA RAO; NAGARAJU MITTAPELLY; RAVIKANTH JALDU; RAVI VIJAYA KRISHNA; MANUKONDA SESHADRI RAO; RAMESH DANDALA; MYLAN LAB LTD 摘要:The present invention provides novel process for the preparation of renin inhibitor Aliskiren or its derivatives, and its pharmaceutically acceptable salts. The present invention also provides novel intermediates used in the preparation of Aliskiren.
专利号:EP-2313386-B1 优先权日:2008-07-23 标 题:Synthesis routes to 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides 发明人:VRIES DE ANDREAS HENDRIKUS MARIA; VERZIJL GERARDUS KAREL MARIA; HERMSEN PETRUS JOHANNES; CASTELIJNS ANNA MARIA CORNELIA FRANCISCA 权利人:DSM IP ASSETS BV 摘要:The invention relates to a process for the preparation of compounds that are important building blocks in convergent synthesis routes to 2(S),4(S),5(S),7(S)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides or pharmaceutically acceptable salts thereof, such as the compound Aliskiren, and to a process for the preparation of these octanoyl amides, comprising reacting said building block.
专利号:ES-2358536-T3 优先权日:2005-09-28 标题 :SYNTHESIS OF RENINAL INHIBITORS INVOLVING A CYCLOADITION REACTION.
1: Kappert K, Unger T, Kintscher U. Aliskiren [Aliskiren hemifumarate]. Dtsch Med Wochenschr. 2008 Jun;133(24):1308-12. German. doi: 10.1055/s-2008-1077232. Epub 2008 May 9. 27(15):4828. doi: 10.3390/molecules27154828. 3: Ali AK. Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor. Ther Clin Risk Manag. 2011;7:337-44. doi: 10.2147/TCRM.S23889. Epub 2011 Aug 9. 4: Salim MM, Ebeid WM, El-Enany N, Belal F, Walash M, Patonay G. Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis. J Sep Sci. 2014 May;37(9-10):1206-13. doi: 10.1002/jssc.201301140. Epub 2014 Mar 25. 53(7):1178-84. doi: 10.1093/chromsci/bmu213. Epub 2015 Jan 9. 47(3):425-6, 428-30. doi: 10.1331/JAPhA.2007.07504. 24(15):2807. doi: 10.3390/molecules24152807.
合成参考文献
参考文献:10.1021/ml200137x 摘要:Jia L, Simpson RD, Yuan J, Xu Z, Zhao W, Cacatian S, Tice CM, Guo J, Ishchenko A, Singh SB, Wu Z, McKeever BM, Bukhtiyarov Y, Johnson JA, Doe CP, Harrison RK, McGeehan GM, Dillard LW, Baldwin JJ, Claremon DA. Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility. ACS Med Chem Lett. 2011 Oct 13;2(10):747–51. 参考文献:10.1021/ml300168e 摘要:Nakamura Y, Fujimoto T, Ogawa Y, Sugita C, Miyazaki S, Tamaki K, Takahashi M, Matsui Y, Nagayama T, Manabe K, Mizuno M, Masubuchi N, Chiba K, Nishi T. Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor. ACS Med Chem Lett. 2012 Sep 13;3(9):754–8. 摘要:https://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01709